Case Study: Xenikos achieves secure, organized due diligence and faster partnerships with ShareVault

Xenikos uses ShareVault to Develop Partnerships with Investors and Strategic Partners

Xenikos, a Netherlands-based biopharmaceutical developing the T-Guard™ immunotherapy, needed partners and investors to advance into a pivotal Phase 3 trial after promising Phase 1b/2 results. Their prior approach—email, intranet and physical data rooms—left technical data fragmented, unsecured, hard to organize, and without customizable permissions or insight into what potential partners were reviewing.

By adopting ShareVault’s secure data room, Xenikos centralized and organized its technical documents, applied tailored access controls, and used analytics to see which materials partners viewed. The result was faster, safer due diligence and more effective partnering discussions: on-demand access, real-time intelligence to prepare meetings, and retained control over shared documents.

Xenikos

Ypke van Oosterhout

Chief Executive Officer